Combined therapy with angiotension receptor-neprilysin inhibitor and sodium-glucose transport protein 2 inhibitors, a real life register data
Event:
Heart Failure 2019
Topic:
Cardiovascular Pharmacotherapy, Other
Session:
Pharmacology and Pharmacotherapy